New Jersey Health Reporter: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on New Jersey Health Reporter.

Press releases published on September 29, 2026

Sep. 29, 2026

Advanced Smile Dentistry Explains Titanium vs. Zirconia in Full-Arch Care

Indeterminate EIN Presswire

Sep. 29, 2026

Dr. Cecilio P. Po of GPC Dental Recognized as a 2026 NJ Top Dentist

Indeterminate EIN Presswire

Sep. 29, 2026

Dr. Rick J. Pumill of Cross County Cardiology - Mt. Sinai Approved As 2026 NJ Top Doc

Indeterminate EIN Presswire

Sep. 29, 2026

Michael Gruber, DMD, FAGD Named NJ Top Dentist For 2026, Honored Since 2015

Indeterminate EIN Presswire

Sep. 29, 2026

Paul Abend, DO, FAAPM&R Named a 2026 NJ Top Doc

Indeterminate EIN Presswire

Sep. 29, 2026

Dr. Laurence C. Breiterman Approved By NJ Top Dentists Based on Merit for 2026

Indeterminate EIN Presswire

Sep. 29, 2026

Amplyfy, Inc Team Attends the Meghan Rose Bradley Foundation Gala

Indeterminate EIN Presswire

Sep. 29, 2026

Alliance Orthopedics Opens First Ocean County Location in Toms River, Expanding Multidisciplinary Care in New Jersey

Indeterminate EIN Presswire

Sep. 29, 2026

MediDepot Shares Practical Guidance for Medical Equipment Procurement During Healthcare Budget Planning

Indeterminate EIN Presswire

Sep. 29, 2026

DBV Technologies Announces Submission of Biologics License Application to U.S. FDA for the VIASKIN® Peanut Patch in Children Aged 4-7 Years

Indeterminate GlobeNewswire

Sep. 29, 2026

DBV Technologies annonce le dépôt de sa demande de licence biologique (BLA) auprès de la Food and Drug Administration des Etats-Unis pour le patch VIASKIN® Peanut destiné aux enfants âgés de 4 à 7 ans.

Indeterminate GlobeNewswire

Sep. 29, 2026

Zealand Pharma to present additional data from Phase 2 ZUPREME-1 trial for petrelintide at EASD 2026 and announces publication of trial results in The Lancet Diabetes & Endocrinology

Indeterminate GlobeNewswire

Sep. 29, 2026

Gain Therapeutics Announces Poster Presentation at International Congress of Parkinson’s Disease and Movement Disorders

Indeterminate GlobeNewswire

Sep. 29, 2026

HL7 Launches Break the Code to Build the Next Generation of Healthcare Interoperability Talent

Indeterminate GlobeNewswire

Sep. 29, 2026

CVRx Announces Late-Breaking Data and New Clinical Evidence on Barostim at the HFSA Annual Scientific Meeting 2026

Indeterminate GlobeNewswire

Sep. 29, 2026

Pyxis Oncology Announces Proposed Public Offering

Indeterminate GlobeNewswire

Sep. 29, 2026

Vireo Growth Inc. Announces Put/Call Agreement in Connection with Loan Acquisition

Indeterminate GlobeNewswire

Sep. 29, 2026

Larimar Therapeutics Strengthens Executive Leadership with Appointment of John Harlow as President and Chief Operating Officer

Indeterminate GlobeNewswire

Sep. 29, 2026

Mineralys Therapeutics Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire

Sep. 29, 2026

Dyne Therapeutics Announces Additional One-Year Clinical Data from Phase 1/2 ACHIEVE Trial of Z-Basivarsen (DYNE-101) for Myotonic Dystrophy Type 1 (DM1)

Indeterminate GlobeNewswire